Meyka Pro banner
NGL Fine-Chem Limited

NGL Fine-Chem Limited Fundamental Analysis (NSE: NGLFINE.NS)

NGLFINE.NSNSE
HealthcareDrug Manufacturers - General
3256.40
58.40(1.83%)
Indian Market is Open · 12:36

NGL Fine-Chem Limited Fundamental Analysis (NSE: NGLFINE.NS)

NGL Fine-Chem Limited (NSE: NGLFINE.NS) shows weak financial fundamentals with a PE ratio of 41.22, profit margin of 9.59%, and ROE of 15.85%. The company generates $5.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio0.32
Current Ratio1.84

Areas of Concern

Cash Position2.24%
We analyze NGLFINE.NS's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 36.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
36.2/100

We analyze NGLFINE.NS's fundamental strength across five key dimensions:

Efficiency Score

Weak

NGLFINE.NS struggles to generate sufficient returns from assets.

ROA > 10%
8.81%

Valuation Score

Moderate

NGLFINE.NS shows balanced valuation metrics.

PE < 25
41.22
PEG Ratio < 2
0.32

Growth Score

Moderate

NGLFINE.NS shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

NGLFINE.NS maintains a strong and stable balance sheet.

Debt/Equity < 1
0.33
Current Ratio > 1
1.84

Profitability Score

Weak

NGLFINE.NS struggles to sustain strong margins.

ROE > 15%
15.85%
Net Margin ≥ 15%
9.59%
Positive Free Cash Flow
No

Key Financial Metrics

Is NGLFINE.NS Expensive or Cheap?

P/E Ratio

NGLFINE.NS trades at 41.22 times earnings. This suggests a premium valuation.

41.22

PEG Ratio

When adjusting for growth, NGLFINE.NS's PEG of 0.32 indicates potential undervaluation.

0.32

Price to Book

The market values NGL Fine-Chem Limited at 6.02 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

6.02

EV/EBITDA

Enterprise value stands at 21.49 times EBITDA. This signals the market has high growth expectations.

21.49

How Well Does NGLFINE.NS Make Money?

Net Profit Margin

For every $100 in sales, NGL Fine-Chem Limited keeps $9.59 as profit after all expenses.

9.59%

Operating Margin

Core operations generate 10.43 in profit for every $100 in revenue, before interest and taxes.

10.43%

ROE

Management delivers $15.85 in profit for every $100 of shareholder equity.

15.85%

ROA

NGL Fine-Chem Limited generates $8.81 in profit for every $100 in assets, demonstrating efficient asset deployment.

8.81%

Following the Money - Real Cash Generation

Operating Cash Flow

NGL Fine-Chem Limited generates limited operating cash flow of $167.72M, signaling weaker underlying cash strength.

$167.72M

Free Cash Flow

NGL Fine-Chem Limited generates weak or negative free cash flow of $-82.44M, restricting financial flexibility.

$-82.44M

FCF Per Share

Each share generates $-13.34 in free cash annually.

$-13.34

FCF Yield

NGLFINE.NS converts -0.42% of its market value into free cash.

-0.42%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

41.22

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.32

vs 25 benchmark

P/B Ratio

Price to book value ratio

6.02

vs 25 benchmark

P/S Ratio

Price to sales ratio

3.95

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.33

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.84

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.16

vs 25 benchmark

ROA

Return on assets percentage

0.09

vs 25 benchmark

ROCE

Return on capital employed

0.13

vs 25 benchmark

How NGLFINE.NS Stacks Against Its Sector Peers

MetricNGLFINE.NS ValueSector AveragePerformance
P/E Ratio41.2229.04 Worse (Expensive)
ROE15.85%484.00% Weak
Net Margin9.59%-71879.00% (disorted) Weak
Debt/Equity0.330.84 Strong (Low Leverage)
Current Ratio1.845.20 Neutral
ROA8.81%-27.00% (disorted) Weak

NGLFINE.NS outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews NGL Fine-Chem Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ